NCT06907576

Completed

Labor Characteristics and Outcomes in Women With Gestational...

Second Affiliated Hospital of Wenzhou Medical University Source

Compare

Other study identifiers

Sponsor study identifier

SAHoWMU-CR2025-07-209

Study Type

observational

Actual enrollment (reported)

425

Locations

1 country

Sites

1

Timeline

Study Start

August 1, 2017

Actual (reported)

Primary Completion

August 1, 2022

Actual (reported)

Study Completion

August 1, 2022

Actual (reported)

Brief Summary

Comparison of Labor Characteristics and Maternal-Neonatal Outcomes in Induced Labor Between Women with Gestational Hypertension/Mild Preeclampsia and Normotensive Controls

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 425 participants
Study completion date: August 1, 2022
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
August 1, 2017
Actual (reported)
Primary Completion
August 1, 2022
Actual (reported)
Study Completion
August 1, 2022
Actual (reported)
First Submitted
March 26, 2025
Actual (reported)
First Posted
April 2, 2025
Actual (reported)

Last Updated: April 2, 2025
Status Verified: March 2025
Last Update Submitted: March 26, 2025

Conditions

Gestational Hypertension Mild Pre-eclampsia

Keywords

induction of laborgestational hypertensionmild pre-eclampsia

Outcome Measures

Primary Outcomes (1)

the rate of cesarean delivery
pregnant outcome
35 weeks to 40 weeks gestation

Study Arms (2)

the HDP group

The pregnant women had combined with gestational hypertension or mild pre-eclampsia.

the normotensive pregnancies group

Eligibility Criteria

Age18 Years - 35 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

This cohort study enrolled 425 pregnant women who underwent IOL, and they were divided into two groups: the HDP group and the normotensive pregnancies group.

You may qualify if:

Undergoing an induction of labor at term (37-42 weeks) who gave birth to a live born, non-anomalous singleton in cephalic presentation, as well as women aged 18-35 years old

Sponsors & Collaborators

Second Affiliated Hospital of Wenzhou Medical University
Otherlead

Study Sites (1)

department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 325027, China

MeSH Terms

Conditions

Hypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

Ying Hua
Second Affiliated Hospital of Wenzhou Medical University
STUDY DIRECTOR

Enrollment

425 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 26, 2025

First Posted

April 2, 2025

Study Start

August 1, 2017

Actual (reported)

NCT03011567

Hypertension In Postpartum Preeclampsia Study

Not ApplicableCompleted

NCT02523781

Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive Pregnancy

Not ApplicableCompleted

NCT03693638

Fractionated Vs Single Dose Injection for Spinal C-Section in Patients With Pregnancy-Induced Hypertension

Not ApplicableCompleted

NCT03111095

Postpartum Hypertension: Remote Patient Monitoring

Not ApplicableCompleted

NCT03556761

Furosemide for Accelerated Recovery of Blood Pressure Postpartum

Phase 2Completed

NCT04031430

PREMOM-II: Pregnancy Remote Monitoring of Women with Gestational Hypertensive Disorders

Not ApplicableCompleted

You may not qualify if:

Women with pregnancy complications including diabetes mellitus, intrahe-patic cholestasis of pregnancy, placenta previa, placental abruption, oligohydramnios, and polyhydramnios, previous caesarean births, fetal birth weight of ≥4.0 kg, severe preeclampsia, chronic hypertension, prepregnancy hypothyroidism and hyperthyroidism, renal system disease, nutritional deficiency, immune system disease, hematological system diseases, and prepregnancy thrombocytopenia. Women were also excluded if clinical data were incomplete.

Contact the study team to confirm eligibility.

Primary Completion

August 1, 2022

Actual (reported)

Study Completion

August 1, 2022

Actual (reported)

Last Updated

April 2, 2025

Record last verified: 2025-03

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT06907576
Data provider: ClinicalTrials.gov
Source updated: 2025-04-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:24:30 UTC

Locations

CN(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

the HDP group

the normotensive pregnancies group

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations